Vera Imper, Ph.D. has served as a member of our Board since December 2021. Dr. Imper served as Vice President and Head, Business Development of Roche Molecular Solutions from January 2018 to November 2021. Dr. Imper previously served as Vice President, Worldwide Business Development of Becton Dickinson Biosciences from May 2009 to October 2017. Dr. Imper currently serves on the advisory board of Barcode Nanotech, a privately funded start-up company. Dr. Imper holds a B.S. in Pharmacy and Biochemistry, an M.S. in Physical and Organic Chemistry, and a Ph.D. in Bioinorganic Chemistry from the University of Zagreb. We believe that Dr. Imper is a seasoned corporate development executive and strategic advisor in the biotechnology industry, with over 25 years of experience driving high-impact mergers, acquisitions, and strategic partnerships. We believe that Dr. Imper's proven track record for identifying growth opportunities in complex markets and extensive experience aligning corporate strategy with financial rigor to guide boards and executive teams through pivotal transformations provide her with the qualifications and skills to serve as a director of the Company.